HOME >> BIOLOGY >> NEWS
Acorda Therapeutics receives L.W. Freeman Award for Scientific Research

Hawthorne, NY /Mesa, AZ November 13, 2002 - Acorda Therapeutics, a biotechnology company located in Hawthorne, NY, will receive the L.W. Freeman Award for Scientific Research tomorrow evening at the National Spinal Cord Injury Association (NSCIA) 2002 Annual Conference in Mesa, AZ.

This award is given annually for pioneering research on regeneration in spinal cord injury or disease and was established in memory of Dr. L. W. Freeman, who was one of the original members of the NSCIA Medical Advisory Committee. A scientist at Indiana University, Dr. Freeman was committed to research that advanced the knowledge of treatment for spinal cord injury. Dr. Freeman was a tireless researcher and teacher, and he served as a key advisor to the Association until his death in 1969.

Marcie Roth, Executive Director of the NSCIA, said, "The NSCIA recognizes the significant contribution that Acorda Therapeutics is making in scientific research that benefits the spinal cord injury community. Acorda's research platform encompasses a broad range of therapeutic targets ranging from regenerative therapies to therapies focused on improved function designed to improve the quality of life and overall health for persons living with a spinal cord injury."

Ron Cohen, M.D., Founder and CEO of Acorda Therapeutics, said, "Acorda is the first company to focus on the development of therapies to restore function in people with SCI. We are proud to be working with the NSCIA to achieve this and are honored to accept this award. Our lead product, Fampridine-SR, entered Phase 3 clinical trials for chronic SCI this year. This is the first time a therapy for improving function in chronic SCI has reached that milestone. Our relationship with the NSCIA continues to be an important catalyst in helping to move the research and education forward in SCI."

The awards ceremony will take place at The Sheraton Mesa Hotel and Convention Center at 6:00 pm on Thursday, November 14, 20
'"/>

Contact: Tierney Saccavino, Acorda
tsaccavino@acorda.com
914-347-4300
Porter Novelli
13-Nov-2002


Page: 1 2

Related biology news :

1. Acorda therapeutics receives NIH Phase 2 grant for central nervous system repair
2. Acorda Therapeutics acquires CeNeS neuregulin products
3. Acorda Therapeutics begins Phase 3 trials of Fampridine-SR for chronic spinal cord injury
4. 16th EORTC NCI AACR Symposium Molecular Targets and Cancer Therapeutics
5. 16th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics
6. PTC Therapeutics researchers identify biochemical pathway important for modulating cell growth
7. Critical Therapeutics announces issuance of US patent for novel anti-inflammatory technology
8. Medimmune and Critical Therapeutics to co-develop treatments for severe inflammatory diseases
9. Immerge BioTherapeutics announces new findings addressing key safety risk in xenotransplantation
10. Critical Therapeutics launches Phase I clinical trial of anti-inflammatory compound
11. Immerge BioTherapeutics announces identification of PERV receptor

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/11/2017)... PALM BEACH GARDENS, Fla. , April 11, ... biometric identity management and secure authentication solutions, today ... million contract by Intelligence Advanced Research Projects Activity ... technologies for IARPA,s Thor program. "Innovation ... the onset and IARPA,s Thor program will allow ...
(Date:4/11/2017)... 2017 NXT-ID, Inc. (NASDAQ:   NXTD ... the appointment of independent Directors Mr. Robin D. Richards ... of Directors, furthering the company,s corporate governance and expertise. ... Gino Pereira , Chief ... to their guidance and benefiting from their considerable expertise as ...
(Date:4/5/2017)... NEW YORK , April 5, 2017 ... security, is announcing that the server component of the ... is known for providing the end-to-end security architecture that ... customers. HYPR has already secured over 15 ... system makers including manufacturers of connected home product suites ...
Breaking Biology News(10 mins):
(Date:10/9/2017)... ... October 09, 2017 , ... At its national board meeting in North ... in Harvard University’s Departments of Physics and Astronomy, has been selected for membership in ... winning team for the 2015 Breakthrough Prize in Fundamental physics for the discovery of ...
(Date:10/9/2017)... , ... October 09, 2017 ... ... on October 5, 2017, in the medical journal, Epilepsia, Brain Sentinel’s SPEAC® ... gold standard, video EEG, in detecting generalized tonic-clonic seizures (GTCS) using surface ...
(Date:10/7/2017)... ... October 06, 2017 , ... ... technologies, launched its ProxiMeta™ Hi-C metagenome deconvolution product, featuring the first commercially ... cloud-based bioinformatics software to perform Hi-C metagenome deconvolution using their own facilities, ...
(Date:10/6/2017)... ... October 06, 2017 , ... The ... and technology sector at their fourth annual Conference where founders, investors, innovative practitioners ... and the ELEVATE pitch competition showcasing early stage digital health and med tech ...
Breaking Biology Technology:
Cached News: